Lack of enrollment

To determine whether treatment with ESTRATEST® Tablets is superior to treatment with esterified estrogens tablets

Inclusion Criteria:

Non-hysterectomized, menopausal women between the ages of 35 and 65 years (inclusive) with symptoms of estrogen and/or androgen deficiency not currently controlled by estrogen therapy as determined by patient report and the Investigator's clinical judgement